Literature DB >> 7948566

Marked increase in cases of coccidioidomycosis in California: 1991, 1992, and 1993.

D Pappagianis1.   

Abstract

Coccidioidomycosis is endemic in California. In an 11-year period from the beginning of 1980 to the end of 1990, an average of approximately 400-500 cases per year were reported to the California State Department of Health Services (CSDHS). In 1990, 441 cases were reported. However, a striking increase in the number of cases was noted in 1991, 1992, and 1993, particularly in the southern San Joaquin Valley counties of Kern and Tulare. In 1992, striking increases were noted in other counties as well. In California there were 1,200 and 4,541 new cases in 1991 and 1992, respectively, that were reported to the CSDHS. The usual rate (5%-7%) of metapulmonary dissemination was noted in these outbreaks, and cases resembling acute adult respiratory distress syndrome that had been noted infrequently in previous outbreaks were conspicuous among the 1991 and 1992 cases. Factors thought to contribute to the extraordinary increases in coccidioidomycosis were a drought of 5 to 6 years' duration; abundant rain in March 1991 and February-March 1992; construction of new buildings; and arrival of new, susceptible individuals to the areas of endemicity.

Entities:  

Mesh:

Year:  1994        PMID: 7948566     DOI: 10.1093/clinids/19.supplement_1.14

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  28 in total

1.  An archived lot of coccidioidin induces specific coccidioidal delayed-type hypersensitivity and correlates with in vitro assays of coccidioidal cellular immune response.

Authors:  Neil M Ampel; Richard F Hector; Christina P Lindan; George W Rutherford
Journal:  Mycopathologia       Date:  2006-02       Impact factor: 2.574

2.  High eosinophils after HALO training: an active-duty soldier with recent travel, nonproductive cough, and eosinophilia.

Authors:  Chad B McBride; Paige Waterman; Richard F Trotta
Journal:  Medscape J Med       Date:  2008-02-26

3.  Evaluation of the proline-rich antigen of Coccidioides immitis as a vaccine candidate in mice.

Authors:  T N Kirkland; F Finley; K I Orsborn; J N Galgiani
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

4.  Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 cDNA.

Authors:  C Jiang; D M Magee; T N Quitugua; R A Cox
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

5.  Coccidioides species determination: does sequence analysis agree with restriction fragment length polymorphism?

Authors:  Suzanne M Johnson; Erin L Carlson; Demosthenes Pappagianis
Journal:  Mycopathologia       Date:  2015-01-11       Impact factor: 2.574

Review 6.  Coccidioides ecology and genomics.

Authors:  Bridget M Barker; Anastasia P Litvintseva; Meritxell Riquelme; Lluvia Vargas-Gastélum
Journal:  Med Mycol       Date:  2019-02-01       Impact factor: 4.076

Review 7.  Update on the Epidemiology of coccidioidomycosis in the United States.

Authors:  Orion Z McCotter; Kaitlin Benedict; David M Engelthaler; Ken Komatsu; Kimberley D Lucas; Janet C Mohle-Boetani; Hanna Oltean; Duc Vugia; Tom M Chiller; Gail L Sondermeyer Cooksey; Alyssa Nguyen; Chandler C Roe; Charlotte Wheeler; Rebecca Sunenshine
Journal:  Med Mycol       Date:  2019-02-01       Impact factor: 4.076

8.  [Coccidioidomycosis as the cause of granulomatous hepatitis].

Authors:  B Zangerl; G Edel; J von Manitius; H A Schmidt-Wilcke
Journal:  Med Klin (Munich)       Date:  1998-03-15

Review 9.  Coccidioidomycosis: host response and vaccine development.

Authors:  Rebecca A Cox; D Mitchell Magee
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

10.  Coccidioidomycosis-Associated Deaths in California, 2000-2013.

Authors:  Gail L Sondermeyer; Lauren A Lee; Debra Gilliss; Duc J Vugia
Journal:  Public Health Rep       Date:  2016 Jul-Aug       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.